Product Information
SUFLAVE POWDER is a brand product labeled by Braintree Laboratories, Inc., priced at $61.6463 per EA under NDC 52268055001. Its NADAC has been published 141 times since Oct 18, 2023.
SUFLAVE POWDER
polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solutionManufacturer
Braintree Laboratories, Inc.NDC
52268055001
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA215344On Market Since
6/15/2023
Price Statistics
The NADAC for SUFLAVE POWDER has been published 141 times since Oct 18, 2023, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $61.6463 per EA |
|---|---|
| All-time high | $61.7751 (May 14, 2025) |
| All-time low | $59.0470 (Oct 18, 2023) |
| 52-week high | $61.6780 |
| 52-week low | $61.6285 |
| Median price | $61.6328 |
| Average price | $60.7343 |
| Largest weekly change | +3.0% (Jan 8, 2025) |
| Weeks tracked | 141 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SUFLAVE POWDER?
The current National Average Drug Acquisition Cost (NADAC) for SUFLAVE POWDER, manufactured by Braintree Laboratories, Inc., is $61.6463 per EA (NDC 52268055001), effective Jun 24, 2026.
How has the price of SUFLAVE POWDER changed over time?
Over the history we have for it, the NADAC for SUFLAVE POWDER has risen 4.4%. It has been tracked across 141 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for SUFLAVE POWDER?
Since Oct 18, 2023, the NADAC for SUFLAVE POWDER has ranged from a low of $59.0470 (Oct 18, 2023) to a high of $61.7751 (May 14, 2025), with a median of $61.6328 per EA.
Are there cheaper alternatives to SUFLAVE POWDER?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SUFLAVE POWDER, so no direct lower-cost alternative is listed.
Who manufactures SUFLAVE POWDER?
SUFLAVE POWDER (NDC 52268055001) is labeled by Braintree Laboratories, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification